Susan M Graham1, Murugi Micheni, Bernadette Kombo, Elisabeth M Van Der Elst, Peter M Mugo, Esther Kivaya, Frances Aunon, Bryan Kutner, Eduard J Sanders, Jane M Simoni. 1. aDepartment of Medicine bDepartment of Global Health cDepartment of Epidemiology, University of Washington, Seattle, Washington, USA dCentre for Geographic Medicine Research - Coast, Kenya Medical Research Institute, Kilifi, Kenya eDepartment of Psychology, University of Washington, Seattle, Washington, USA fNuffield Department of Medicine, University of Oxford, Headington, UK gDepartment of Global Health, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
Abstract
OBJECTIVES: In many African settings, MSM are a stigmatized group whose access to and engagement in HIV care may be challenging. Our aim was to design a targeted, culturally appropriate intervention to promote care engagement and antiretroviral therapy (ART) adherence for MSM in coastal Kenya, and describe intervention safety, feasibility, and acceptability based upon a small pilot study. DESIGN: Based on qualitative work including in-depth interviews with HIV-positive MSM and focus groups with providers, we developed a tailored intervention and conducted a pilot test to refine intervention materials and procedures. METHODS: The Shikamana intervention combines modified Next-Step Counseling by trained providers, support from a trained peer navigator, and tailored use of SMS messaging, phone calls, and discrete pill carriers. Providers, including counselors and clinicians, work together with peer navigators as a case management team. RESULTS:Forty HIV-positive MSM aged 19-51 participated in intervention development and testing. Six counselors, three clinical officers, and four MSM peers were trained in intervention procedures. Of 10 ART-naïve participants who enrolled in the pilot, eight completed follow-up with no adverse events reported. One participant was lost to follow-up after 2 months and another failed to initiate ART despite ongoing counseling. No adverse events were reported. Staff feedback and exit interviews rated the intervention as feasible and acceptable. CONCLUSION: This adherence support intervention tailored for Kenyan MSM was well tolerated, feasible, and acceptable in the pilot phase. A randomized controlled trial of a scaled-up programme to estimate intervention efficacy is ongoing.
RCT Entities:
OBJECTIVES: In many African settings, MSM are a stigmatized group whose access to and engagement in HIV care may be challenging. Our aim was to design a targeted, culturally appropriate intervention to promote care engagement and antiretroviral therapy (ART) adherence for MSM in coastal Kenya, and describe intervention safety, feasibility, and acceptability based upon a small pilot study. DESIGN: Based on qualitative work including in-depth interviews with HIV-positive MSM and focus groups with providers, we developed a tailored intervention and conducted a pilot test to refine intervention materials and procedures. METHODS: The Shikamana intervention combines modified Next-Step Counseling by trained providers, support from a trained peer navigator, and tailored use of SMS messaging, phone calls, and discrete pill carriers. Providers, including counselors and clinicians, work together with peer navigators as a case management team. RESULTS: Forty HIV-positive MSM aged 19-51 participated in intervention development and testing. Six counselors, three clinical officers, and four MSM peers were trained in intervention procedures. Of 10 ART-naïve participants who enrolled in the pilot, eight completed follow-up with no adverse events reported. One participant was lost to follow-up after 2 months and another failed to initiate ART despite ongoing counseling. No adverse events were reported. Staff feedback and exit interviews rated the intervention as feasible and acceptable. CONCLUSION: This adherence support intervention tailored for Kenyan MSM was well tolerated, feasible, and acceptable in the pilot phase. A randomized controlled trial of a scaled-up programme to estimate intervention efficacy is ongoing.
Authors: Anjali Sharma; Elizabeth Bukusi; Pamina Gorbach; Craig R Cohen; Charles Muga; Z Kwena; King K Holmes Journal: Sex Transm Dis Date: 2008-04 Impact factor: 2.830
Authors: Chris Beyrer; Stefan D Baral; Frits van Griensven; Steven M Goodreau; Suwat Chariyalertsak; Andrea L Wirtz; Ron Brookmeyer Journal: Lancet Date: 2012-07-20 Impact factor: 79.321
Authors: Elise M van der Elst; Adrian D Smith; Evanson Gichuru; Elizabeth Wahome; Helgar Musyoki; Nicolas Muraguri; Greg Fegan; Zoe Duby; Linda-Gail Bekker; Bonnie Bender; Susan M Graham; Don Operario; Eduard J Sanders Journal: J Int AIDS Soc Date: 2013-12-02 Impact factor: 5.396
Authors: Elise M van der Elst; Evans Gichuru; Anisa Omar; Jennifer Kanungi; Zoe Duby; Miriam Midoun; Sylvia Shangani; Susan M Graham; Adrian D Smith; Eduard J Sanders; Don Operario Journal: J Int AIDS Soc Date: 2013-12-02 Impact factor: 5.396
Authors: Lillian B Brown; James Ayieko; Florence Mwangwa; Asiphas Owaraganise; Dalsone Kwarisiima; Vivek Jain; Theodore Ruel; Tamara Clark; Douglas Black; Gabriel Chamie; Elizabeth A Bukusi; Craig R Cohen; Moses R Kamya; Maya L Petersen; Edwin D Charlebois; Diane V Havlir Journal: J Acquir Immune Defic Syndr Date: 2017-09-01 Impact factor: 3.731
Authors: Susan M Graham; Duncan O Okall; Supriya D Mehta; Eve Obondi; George Ng'ety; Elijah Ochieng; Laura Jadwin-Cakmak; K Rivet Amico; Gary W Harper; Robert C Bailey; Fredrick O Otieno Journal: AIDS Behav Date: 2022-10-11
Authors: Susan M Graham; Murugi Micheni; Oscar Chirro; Joseph Nzioka; Andrew M Secor; Peter M Mugo; Bernadette Kombo; Elise M van der Elst; Don Operario; K Rivet Amico; Eduard J Sanders; Jane M Simoni Journal: AIDS Behav Date: 2020-07
Authors: Lisa M Kuhns; Amy K Johnson; Adedotun Adetunji; Kehinde M Kuti; Robert Garofalo; Olayinka Omigbodun; Olutosin A Awolude; Bibilola D Oladeji; Baiba Berzins; Ogochukwu Okonkwor; Oluwaseun P Amoo; Omolade Olomola; Babafemi Taiwo Journal: PLoS One Date: 2021-10-06 Impact factor: 3.752
Authors: Murugi Micheni; Bernadette K Kombo; Andrew Secor; Jane M Simoni; Don Operario; Elise M van der Elst; Peter Mugo; Jennifer Kanungi; Eduard J Sanders; Susan M Graham Journal: AIDS Patient Care STDS Date: 2017-02-22 Impact factor: 5.078
Authors: Daniel Nyato; Evodius Kuringe; Mary Drake; Caterina Casalini; Soori Nnko; Amani Shao; Albert Komba; Stefan D Baral; Mwita Wambura; John Changalucha Journal: BMC Public Health Date: 2018-03-20 Impact factor: 3.295
Authors: Susan M Graham; Murugi Micheni; Andrew Secor; Elise M van der Elst; Bernadette Kombo; Don Operario; K Rivet Amico; Eduard J Sanders; Jane M Simoni Journal: AIDS Care Date: 2019-01-22